Literature DB >> 17940109

Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.

Mark O Goodarzi1, Michelle R Jones, Heath J Antoine, Marita Pall, Yii-Der I Chen, Ricardo Azziz.   

Abstract

CONTEXT: Increased androgen production is a primary feature of polycystic ovary syndrome (PCOS) and appears to be an inherited trait. The gene for the steroidogenic enzyme type 5 17beta hydroxysteroid dehydrogenase (HSD17B5) was implicated as a candidate for the hyperandrogenemia of PCOS by a previous study that demonstrated an association of a single nucleotide polymorphism (SNP) in the promoter of this gene with PCOS.
OBJECTIVE: The objective of the study was to replicate the previous report of association between the HSD17B5 gene and PCOS risk by genotyping the promoter SNP (as well as other SNPs in the region to provide improved coverage of the gene) in a large, well-characterized cohort suitable for replication study.
DESIGN: Women with and without PCOS were genotyped for five SNPs in HSD17B5. SNPs and haplotypes were determined and tested for association with PCOS risk and phenotypic markers of PCOS.
SETTING: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; controls were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. PARTICIPANTS: Participants included 287 white women with PCOS and 187 white controls. MAIN MEASUREMENTS: HSD17B5 genotype, PCOS risk, and testosterone levels were measured.
RESULTS: No SNP or haplotype was significantly associated with PCOS risk, testosterone, or any of the traits tested.
CONCLUSIONS: These data suggest that polymorphisms in the HSD17B5 gene are not associated with PCOS risk or elevated testosterone as previously reported.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940109      PMCID: PMC2190745          DOI: 10.1210/jc.2007-1712

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

Review 3.  Genetics of ovarian disorders: polycystic ovary syndrome.

Authors:  Stephen Franks; Mark McCarthy
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

4.  Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.

Authors:  Nicole Draper; Brenda L Powell; Steve Franks; Gerard S Conway; Paul M Stewart; Mark I McCarthy
Journal:  Clin Endocrinol (Oxf)       Date:  2006-07       Impact factor: 3.478

5.  Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).

Authors:  T M Penning; M E Burczynski; J M Jez; H K Lin; H Ma; M Moore; K Ratnam; N Palackal
Journal:  Mol Cell Endocrinol       Date:  2001-01-22       Impact factor: 4.102

6.  The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.

Authors:  V L Nelson; K N Qin; R L Rosenfield; J R Wood; T M Penning; R S Legro; J F Strauss; J M McAllister
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 7.  The genetics of the polycystic ovary syndrome.

Authors:  Margrit Urbanek
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

8.  Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans.

Authors:  Mark O Goodarzi; Xiuqing Guo; Kent D Taylor; Manuel J Quiñones; Carlos Samayoa; Huiying Yang; Mohammad F Saad; Aarno Palotie; Ronald M Krauss; Willa A Hsueh; Jerome I Rotter
Journal:  Genet Med       Date:  2003 Jul-Aug       Impact factor: 8.822

9.  Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.

Authors:  Michelle Gaasenbeek; Brenda L Powell; Ulla Sovio; Lema Haddad; Neda Gharani; Amanda Bennett; Christopher J Groves; Karen Rush; Micaela J Goh; Gerard S Conway; Aimo Ruokonen; Hannu Martikainen; Anneli Pouta; Saara Taponen; Anna-Liisa Hartikainen; Stephanie Halford; Marjo-Riitta Järvelin; Steve Franks; Mark I McCarthy
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

10.  Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche.

Authors:  Clive J Petry; Ken K Ong; Dianne L Wingate; Francis de Zegher; Lourdes Ibáñez; David B Dunger
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-17       Impact factor: 4.292

View more
  14 in total

1.  Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis.

Authors:  Yasuhiro Nakamura; Peter J Hornsby; Peter Casson; Ryo Morimoto; Fumitoshi Satoh; Yewei Xing; Michael R Kennedy; Hironobu Sasano; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

2.  Polycystic ovary syndrome is a family affair.

Authors:  Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2008-05       Impact factor: 5.958

3.  Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.

Authors:  D M Liu; L C Torchen; Y Sung; R Paparodis; R S Legro; S K Grebe; R J Singh; R L Taylor; A Dunaif
Journal:  Hum Reprod       Date:  2014-10-21       Impact factor: 6.918

Review 4.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

Review 5.  Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome.

Authors:  Márcia Marly Winck Yamamoto; Sebastião Freitas de Medeiros
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

6.  Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.

Authors:  Mark O Goodarzi; Yvonne V Louwers; Kent D Taylor; Michelle R Jones; Jinrui Cui; Soonil Kwon; Yii-Der I Chen; Xiuqing Guo; Lisette Stolk; André G Uitterlinden; Joop S E Laven; Ricardo Azziz
Journal:  Fertil Steril       Date:  2011-04       Impact factor: 7.329

7.  Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.

Authors:  Michelle R Jones; Ruchi Mathur; Jinrui Cui; Xiuqing Guo; Ricardo Azziz; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

8.  KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women.

Authors:  Xiaofei Du; Robert L Rosenfield; Kenan Qin
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

9.  Lack of association between interleukin-1a gene (IL-1a) C (-889) T variant and polycystic ovary syndrome in Chinese women.

Authors:  Binbin Wang; Sirui Zhou; Jing Wang; Jingjing Liu; Feng Ni; Chunmei Liu; Jinting Yan; Yuan Mu; Yunxia Cao; Xu Ma
Journal:  Endocrine       Date:  2009-02-04       Impact factor: 3.633

10.  Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer.

Authors:  Jenny J Schulze; Helena Karypidis; Lena Ekström
Journal:  Front Pharmacol       Date:  2012-08-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.